GI
GenoPalate, Inc.
SEC filingBiotechnology · Milwaukee, WI
Amount raised$250Ksold at filing
Total offering$3M$2.8M still open
Investors in the raise1count reported to the SEC
FiledMar 4, 2026first sale Feb 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Joseph M. SmithDirector
Yi T. ZhangDirector
Asif T. NaseemExecutive Officer, Director
John T. ByrnesDirector
Harald M. SteltzerDirector
Michael T. McNallyExecutive Officer
Executive officers, directors and promoters as listed on the Form D.